Copeptin Does Not Add Diagnostic Information to High-Sensitivity Troponin T in Low- to Intermediate-Risk Patients with Acute Chest Pain: Results from the Rule Out Myocardial Infarction by Computed Tomography (ROMICAT) Study

Karakas, Mahir; Januzzi, James; Meyer, Julia; Lee, Hang; Schlett, Christopher; Truong, Quynh; Rottbauer, Wolfgang; Bamberg, Fabian; Dasdemir, SELÇUK; Hoffmann, Udo; Koenig, Wolfgang

doi:10.1373/clinchem.2010.160192

Copeptin Does Not Add Diagnostic Information to High-Sensitivity Troponin T in Low- to Intermediate-Risk Patients with Acute Chest Pain: Results from the Rule Out Myocardial Infarction by Computed Tomography (ROMICAT) Study

Karakas M., Januzzi J. L., Meyer J., Lee H., Schlett C. L., Truong Q. A., ...Daha Fazla

CLINICAL CHEMISTRY, cilt.57, sa.8, ss.1137-1145, 2011 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 57 Sayı: 8
Basım Tarihi: 2011
Doi Numarası: 10.1373/clinchem.2010.160192
Dergi Adı: CLINICAL CHEMISTRY
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1137-1145
Açık Arşiv Koleksiyonu: AVESİS Açık Erişim Koleksiyonu
İstanbul Üniversitesi Adresli: Hayır

Özet

PURPOSE: Copeptin, a stable peptide derived from the AVP precursor, has been linked to presence and severity of myocardial ischemia. We sought to evaluate the predictive value of copeptin and its incremental value beyond that of high-sensitivity cardiac troponin T (hs-cTnT) in patients with acute chest pain and low to intermediate risk for acute coronary syndrome (ACS).